Astal Laboratories [ASTALLTD] vs Spencer's Retail [SPENCERS] Detailed Stock Comparison
Astal Laboratories
BSE
Loading...
Spencer's Retail
NSE
Loading...
TLDR: Quick Comparison Summary
Based on 19 vital metrics comparison: Astal Laboratories wins in 6 metrics, Spencer's Retail wins in 12 metrics, with 0 ties. Spencer's Retail appears stronger overall.
View Metrics Details
Vital Metrics Comparison
| Metric | Astal Laboratories | Spencer's Retail | Better |
|---|---|---|---|
| P/E Ratio (TTM) | 10.16 | -2.04 | Spencer's Retail |
| Price-to-Book Ratio | 2.23 | -0.76 | Spencer's Retail |
| Debt-to-Equity Ratio | 36.86 | -2.38 | Spencer's Retail |
| PEG Ratio | 0.43 | -0.05 | Spencer's Retail |
| EV/EBITDA | 7.29 | -100.56 | Spencer's Retail |
| Profit Margin (TTM) | 12.33% | -14.20% | Astal Laboratories |
| Operating Margin (TTM) | 11.14% | -7.93% | Astal Laboratories |
| EBITDA Margin (TTM) | 11.14% | N/A | N/A |
| Return on Equity | 24.80% | 37.24% | Spencer's Retail |
| Return on Assets (TTM) | 14.09% | -18.81% | Astal Laboratories |
| Free Cash Flow (TTM) | $-182.92M | $154.16M | Spencer's Retail |
| 1-Year Return | -20.02% | -47.87% | Astal Laboratories |
| Price-to-Sales Ratio (TTM) | 1.17 | 0.27 | Spencer's Retail |
| Enterprise Value | $940.80M | $20.58B | Spencer's Retail |
| EV/Revenue Ratio | 1.24 | 1.11 | Spencer's Retail |
| Gross Profit Margin (TTM) | 15.24% | 20.83% | Spencer's Retail |
| Revenue per Share (TTM) | $77 | $207 | Spencer's Retail |
| Earnings per Share (Diluted) | $8.06 | $-29.39 | Astal Laboratories |
| Beta (Stock Volatility) | -0.81 | 0.12 | Astal Laboratories |
Performance
News Sentiment
Key Stats
Valuation
Financials
Short Interest
Dividends
Astal Laboratories vs Spencer's Retail Stock Performance Analysis
Loading Price Chart...
Performance Comparison
Short-term Returns
| Stock | 1D | 1W | 1M | 3M | 6M | YTD |
|---|---|---|---|---|---|---|
| Astal Laboratories | -0.02% | 4.34% | 4.66% | 8.71% | 3.73% | 9.47% |
| Spencer's Retail | -1.47% | -4.25% | -6.79% | -10.82% | -17.10% | -32.42% |
Long-term Returns
| Stock | 1Y | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|
| Astal Laboratories | -20.02% | 91.08% | 91.08% | 91.08% | 91.08% | 91.08% |
| Spencer's Retail | -47.87% | -27.69% | -27.97% | -73.97% | -73.97% | -73.97% |
News Based Sentiment: Astal Laboratories vs Spencer's Retail
Astal Laboratories
News based Sentiment: MIXED
September brought strong financial results and a successful AGM for Astal Laboratories, signaling positive momentum. However, the persistent negative cash flow from operations introduces a significant risk factor, creating a mixed investment narrative. The combination of growth and ongoing challenges makes this a noteworthy month for investors.
Spencer's Retail
News based Sentiment: NEGATIVE
September presented a series of negative developments for Spencer's Retail, including a declining stock price, weak financials, and reduced institutional investment. While the Pluckk partnership offers some potential, it's insufficient to offset the significant concerns surrounding the company's performance and future prospects, making it a critical month for investors to reassess their positions.
Performance & Financial Health Analysis: Astal Laboratories vs Spencer's Retail
| Metric | ASTALLTD | SPENCERS |
|---|---|---|
| Market Information | ||
| Market Cap | ₹889.93M | ₹5.01B |
| Market Cap Category | Small cap | Small cap |
| 10 Day Avg. Volume | 1,311,607 | 87,953 |
| 90 Day Avg. Volume | 452,141 | 108,486 |
| Last Close | ₹86.10 | ₹54.82 |
| 52 Week Range | ₹66.72 - ₹101.37 | ₹53.76 - ₹110.90 |
| % from 52W High | -15.06% | -50.57% |
| All-Time High | ₹131.70 (Sep 09, 2024) | ₹225.00 (Jan 21, 2019) |
| % from All-Time High | -34.62% | -75.64% |
| Growth Metrics | ||
| Quarterly Revenue Growth | 0.91% | -0.24% |
| Quarterly Earnings Growth | 0.24% | -0.24% |
| Financial Health | ||
| Profit Margin (TTM) | 0.12% | -0.14% |
| Operating Margin (TTM) | 0.11% | -0.08% |
| Return on Equity (TTM) | 0.25% | 0.37% |
| Debt to Equity (MRQ) | 36.86 | -2.38 |
| Cash & Liquidity | ||
| Book Value per Share (MRQ) | ₹36.75 | ₹-73.40 |
| Cash per Share (MRQ) | ₹1.76 | ₹2.86 |
| Operating Cash Flow (TTM) | ₹-116,989,000 | ₹-333,617,000 |
| Levered Free Cash Flow (TTM) | ₹89.25M | ₹-2,463,623,000 |
| Dividends | ||
| Last 12-Month Dividend Yield | N/A | N/A |
| Last 12-Month Dividend | N/A | N/A |
Valuation & Enterprise Metrics Analysis: Astal Laboratories vs Spencer's Retail
| Metric | ASTALLTD | SPENCERS |
|---|---|---|
| Price Ratios | ||
| P/E Ratio (TTM) | 10.16 | -2.04 |
| Forward P/E | N/A | N/A |
| PEG Ratio | 0.43 | -0.05 |
| Price to Sales (TTM) | 1.17 | 0.27 |
| Price to Book (MRQ) | 2.23 | -0.76 |
| Market Capitalization | ||
| Market Capitalization | ₹889.93M | ₹5.01B |
| Enterprise Value | ₹940.80M | ₹20.58B |
| Enterprise Value Metrics | ||
| Enterprise to Revenue | 1.24 | 1.11 |
| Enterprise to EBITDA | 7.29 | -100.56 |
| Risk & Other Metrics | ||
| Beta | -0.81 | 0.12 |
| Book Value per Share (MRQ) | ₹36.75 | ₹-73.40 |
Financial Statements Comparison: Astal Laboratories vs Spencer's Retail
Financial Metrics
Loading Financial Charts...
Revenue
EBITDA
Operating Margin
Free Cash Flow
Long Term Debt
Profit Margin
Current Ratio
Operating Cash Flow
Income Statement (MRQ)
| Metric (MRQ) | ASTALLTD | SPENCERS |
|---|---|---|
| Revenue/Sales | ₹253.27M | ₹4.16B |
| Cost of Goods Sold | ₹214.66M | ₹3.29B |
| Gross Profit | ₹38.61M | ₹866.33M |
| Research & Development | N/A | N/A |
| Operating Income (EBIT) | ₹30.38M | ₹-329.80M |
| EBITDA | ₹32.14M | ₹47.35M |
| Pre-Tax Income | ₹27.93M | ₹-616.68M |
| Income Tax | ₹7.03M | ₹-581,000 |
| Net Income (Profit) | ₹20.90M | ₹-616.10M |
Balance Sheet & Liquidity Metrics (MRQ)
| Metric (MRQ) | ASTALLTD | SPENCERS |
|---|---|---|
| Cash & Equivalents | ₹17.30M | ₹216.91M |
| Total Current Assets | ₹456.39M | ₹2.52B |
| Total Current Liabilities | ₹267.71M | ₹9.77B |
| Long-Term Debt | ₹4.56M | ₹9.59B |
| Total Shareholders Equity | ₹359.95M | ₹-6.62B |
| Retained Earnings | ₹107.05M | ₹-13.39B |
| Property, Plant & Equipment | ₹0 | ₹5.11B |
Cash Flow Statement Comparison (MRQ)
| Metric (MRQ) | ASTALLTD | SPENCERS |
|---|---|---|
| Operating Cash Flow | N/A | N/A |
| Capital Expenditures | N/A | N/A |
| Free Cash Flow | N/A | N/A |
| Debt Repayment | N/A | N/A |
| Common Stock Repurchase | N/A | N/A |
Short Interest & Institutional Ownership Analysis
| Metric | ASTALLTD | SPENCERS |
|---|---|---|
| Shares Short | N/A | N/A |
| Short Ratio | N/A | N/A |
| Short % of Float | N/A | N/A |
| Average Daily Volume (10 Day) | 1,311,607 | 87,953 |
| Average Daily Volume (90 Day) | 452,141 | 108,486 |
| Shares Outstanding | 9.83M | 90.01M |
| Float Shares | 4.10M | 34.72M |
| % Held by Insiders | 0.57% | 0.62% |
| % Held by Institutions | 0.00% | 0.09% |
Dividend Analysis & Yield Comparison: Astal Laboratories vs Spencer's Retail
| Metric | ASTALLTD | SPENCERS |
|---|---|---|
| Last 12-Month Dividend | N/A | N/A |
| Last 12-Month Dividend Yield | N/A | N/A |
| 3-Year Avg Annual Dividend | N/A | N/A |
| 3-Year Avg Dividend Yield | N/A | N/A |
| 3-Year Total Dividends | N/A | N/A |
| Ex-Dividend Date | N/A | N/A |